- Draig bags another $65M to speed testing of brain drugsThe cash will support mid-stage trials of a prospect the company claims to have “best-in-disease” potential treating major depressive disorder.BioPharma Dive · 14d ago↗ source
- The risk of refusing a newborn’s vitamin K shotHealth care workers on strike at Ebola treatment center, how to tackle the U.S. alcohol epidemic, and more Morning Rounds newsSTAT · 14d ago↗ source
- STAT+: Pharmalittle: We’re reading about a battle between Lilly and Teva, psychedelic drugs, and moreA U.S. appeals court revived a Teva Pharmaceuticals lawsuit accusing Eli Lilly of breaching an agreement allowing Teva to market a generic version of ForteoSTAT · 14d ago↗ source